| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 737.90M | 526.50M | 429.80M | 256.70M | 128.40M |
| Gross Profit | 0.00 | 172.70M | 90.20M | 28.40M | 22.90M |
| EBITDA | 0.00 | -183.90M | -209.80M | -282.60M | -229.90M |
| Net Income | -165.50M | -202.20M | -236.90M | -297.80M | -241.30M |
Balance Sheet | |||||
| Total Assets | 1.93B | 1.85B | 1.63B | 1.69B | 1.51B |
| Cash, Cash Equivalents and Short-Term Investments | 396.80M | 1.01B | 937.70M | 1.03B | 1.07B |
| Total Debt | 0.00 | 107.20M | 43.10M | 35.20M | 22.30M |
| Total Liabilities | 1.39B | 1.26B | 924.40M | 823.90M | 522.30M |
| Stockholders Equity | 533.60M | 593.40M | 708.90M | 866.80M | 988.20M |
Cash Flow | |||||
| Free Cash Flow | -25.90M | -20.80M | -128.30M | -173.10M | -154.00M |
| Operating Cash Flow | -16.50M | -11.40M | -119.10M | -163.00M | -144.60M |
| Investing Cash Flow | -89.10M | 40.60M | 88.70M | 181.10M | -804.80M |
| Financing Cash Flow | 106.60M | 87.70M | 15.40M | 3.60M | 649.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $3.21B | 16.94 | 23.58% | ― | 54.41% | 52.71% | |
76 Outperform | $120.84B | 10.72 | ― | 2.20% | 18.35% | 32.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | $896.21M | 19.59 | 17.02% | ― | 38.50% | ― | |
56 Neutral | $1.83B | 13.65 | 9.03% | 3.15% | 4.51% | -8.29% | |
50 Neutral | $3.90B | -21.82 | -31.34% | ― | 30.53% | 21.82% |
Lemonade, Inc., which operates a technology-focused consumer insurance platform, issued 7,846,646 warrants with an exercise price of $218.51 as part of its November 8, 2021 merger agreement with Metromile, Inc. These Lemonade warrants, listed on the NYSE under the LMND-WS ticker, are scheduled to expire on February 9, 2026 at 5:00 p.m. Eastern Time, and the exchange has notified the company that trading in the warrants will be suspended after the market close on February 5, 2026 to allow for timely settlement ahead of expiration, affecting warrant holders’ remaining window to exercise or trade these instruments.
The most recent analyst rating on (LMND) stock is a Hold with a $101.00 price target. To see the full list of analyst forecasts on Lemonade stock, see the LMND Stock Forecast page.